BioNTech SE ( (BNTX) ) has shared an update.
On April 4, 2025, BioNTech SE announced the invitation to its Annual General Meeting scheduled for May 16, 2025. The meeting will be conducted virtually, allowing shareholders to participate electronically. Key agenda items include the presentation of financial statements for 2024, resolutions on profit appropriation, and the appointment of auditors for 2025. The company also plans to create new Authorized Capital 2025 to enhance financial flexibility, replacing the existing Authorized Capital 2021.
More about BioNTech SE
BioNTech SE is a biotechnology company based in Mainz, Germany, specializing in the development of immunotherapies for cancer and infectious diseases. The company is known for its mRNA technology, which was pivotal in the development of the COVID-19 vaccine.
YTD Price Performance: -20.20%
Average Trading Volume: 849,510
Technical Sentiment Signal: Strong Buy
Current Market Cap: $22.08B
See more data about BNTX stock on TipRanks’ Stock Analysis page.